The YpsoDose patch injector device. [Image courtesy of Ypsomed]
Burgdorf, Switzerland-based Ypsomed designed YpsoDose for the subcutaneous self-injection of large-volume doses. ten23 health, a Swiss CDMO, offers drug development, filling and device assembly expertise to contribute to the product offering.
The strategic collaboration sees both parties proactively invest in technology and infrastructure. They want to offer YpsoDose as a fully integrated patch injector. YpsoDose includes a ready-to-use cartriQ glass cartridge from Schott Pharma as the primary packaging, Ypsomed’s patch injector technology and process development, filling, assembly and testing of the final product by ten23 health.
Get the full story at our sister site, Drug Delivery Business News.
Filed Under: Drug Delivery, Drug Discovery and Development
